Chemoembolisation of hepatocellular carcinomas: personal experience

Ettorre, G; Garribba, A. P.; Francisco, Gallegos-Hernández José; Mirizzi, F.; Elba, Silvana; Mossa, Ascanio; Martino, Fabio

doi:10.1007/bf00187548

Cited by 1 publication

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…31 There is marked variation in protocols used in different centres. 4,[32][33][34][35][36][37][38][39] Table 1 shows chemotherapeutic agents used at Vancouver General Hospital. Intra-arterial lidocaine can be injected into the hepatic artery before the chemotherapeutic agent(s) injection to reduce pain caused by the chemotherapeutic mixture (likely to be secondary to capsular irritation).…”

Section: Patient Selectionmentioning

confidence: 99%

“…Quoted response and survival rates, however, vary widely. 20,31,32,36,39,[47][48][49][50][51][52][53][54][55][56][57][58][59] The response rates of patients with unresectable HCC treated with chemo-embolization in Asia, Europe and the United States vary widely. Survival ranged from 54 to 88% at 1 year, 33-64% at 2 years, and 18-51% at 3 years in the papers cited here, although this is by no means an exhaustive survey.…”

Section: Hepatomamentioning

confidence: 99%

See 1 more Smart Citation

Chemo‐embolization of hepatic tumours

al-Bassam

Pl²,

Sallomi³

et al. 1999

Australasian Radiology

View full text Add to dashboard Cite

Over the past decade, increasing use of chemo-embolization with chemotherapeutic agents emulsified in oil has been made in the treatment of both primary and metastatic liver tumours. These lesions are often not amenable to surgical resection and are not responsive to systemic chemotherapy. Chemo-embolization provides an additional therapeutic option which, in some instances, can provide significant benefit. This pictorial review discusses the technique of chemo-embolization, as well as aspects of patient selection, complications, and tumour response.

show abstract